Methotrexate (MTX) and etanercept (ETN) improve the health-related quality of life (HRQOL) of children with juvenile idiopathic arthritis (JIA).

R Gutierrez-Suarez, A Cespedes, A Ravelli, K Murray, V Gerloni, N Wulffraat, S Oliveira, J Walsh, I Calvo, MG Alpigiani, P Lahdenne, C Machado, E Cortis, L Lepore, A Hall, A Martin, R Burgos-Vargas, N Ruperto

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)426-426
JournalJournal of Rheumatology
Volume33
Issue number2
Publication statusPublished - Feb 2006

Cite this